Open AccessA Case of Bronchiolitis Obliterans Organizing Pneumonia Following CHOP Chemotherapy and Filgrastim Use in a Patient with Diffuse Large B-cell Lymphoma
Author(s) -
Wou Young Chung,
Min Kwang Byun,
Jin Hyoung Lee,
Chang Hoon Hahn,
Shin Myung Kang,
Jin Seok Kim,
San Ho Cho,
Young Sam Kim,
Soon Il Kim,
Joon Chang,
Sung Kyu Kim,
Moo Suk Park
Publication year - 2005
Publication title -
tuberculosis and respiratory diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.837
H-Index - 24
eISSN - 2005-6184
pISSN - 1738-3536
DOI - 10.4046/trd.2005.59.5.561
Subject(s) - medicine , bronchiolitis obliterans organizing pneumonia , etiology , filgrastim , chop , bronchiolitis obliterans , pneumonia , chemotherapy , lymphoma , intensive care medicine , dermatology , granulocyte colony stimulating factor , lung , lung transplantation
Bronchiolitis obliterans organizing pneumonia (BOOP) is often diagnosed in patients with pneumonia who respond poorly to antibiotics. BOOP is often idiopathic, and the etiology of the remaining cases has been attributed to a wide range of agents or medical conditions. When a patient develops the clinical symptoms characteristic of BOOP, the medical team must endeavor to determine the etiology of this disease because it can be treated with glucocorticoid and avoidance of the causative agent. In particular, if BOOP is diagnosed during or after chemotherapy for a malignancy, the possible culprit agent can be the anti cancer drugs but other drugs used for supportive care must be also be considered. We report a case of BOOP that arose after CHOP chemotherapy and a filgrastim injection in a patient with a diffuse large B-cell lymphoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom